Medical News

RSS

Zoetis reports revenue of $1.25 billion for Q4 2013

Zoetis Inc. today reported its financial results for the fourth quarter and full year 2013. The company reported revenue of $1.25 billion for the fourth quarter of 2013, an increase of 7% from the fourth quarter of 2012. Revenue reflected an operational increase of 9%, with foreign currency having a negative impact of 2 percentage points.

11 Feb 2014

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.

11 Feb 2014

Cambrex fourth quarter sales increase 46.3% to $103 million

Cambrex Corporation reports results for the fourth quarter and full year ended December 31, 2013.

11 Feb 2014

Cardiome Pharma's subsidiary signs agreement with Tamro to distribute BRINAVESS in Sweden

Cardiome Pharma Corp. today announced that its subsidiary, Correvio GmbH, has entered into an agreement with Tamro AB, headquartered in Gothenburg, Sweden, to distribute BRINAVESS (vernakalant IV) to customers in the Swedish market.

11 Feb 2014

Henry Schein net sales increase 4.9% to $2.5 billion in fourth quarter 2013

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended December 28, 2013.

11 Feb 2014

Weekend maintenance will affect HealthCare.gov

Meanwhile, Maryland officials say the problems with that state's enrollment website are unlikely to be fixed before the March 31 enrollment deadline. Elsewhere, California is hiring more call center workers, and Illinois is reaching out to young adults with ads in the satirical online newspaper, The Onion.

11 Feb 2014

Omeros announces additional positive data from OMS824 Phase 1 program

Omeros Corporation today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition. In the latest cohort enrolled in this trial, OMS824 achieved a high of approximately 70‑percent engagement at PDE10 without evidence of extrapyramidal symptoms (EPS).

11 Feb 2014

MedAptus releases Risk Severity Toolkit to help provider groups manage disease burden of patients

MedAptus today announced that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. The initial version focuses on the Medicare Advantage (MA) patient population where premiums paid to MA health plans are based on enrollees' severity history using the Centers for Medicare and Medicaid Services Hierarchical Condition Categories (HCC) model.

11 Feb 2014

Pivot Point named one of Seven Small Jewels of 2014

Pivot Point Consulting, LLC, has been named one of the Seven Small Jewels of 2014 by Consulting Magazine. This prestigious annual award recognizes consulting firms that continue to grow and whose service makes them stand out from the rest in their field.

11 Feb 2014

New hemostasis valve with sideport tubing and stopcock launched by Qosina

...

11 Feb 2014

UPS completes acquisition of U.K.-based Polar Speed

UPS today announced it has completed the purchase of U.K.-based Polar Speed, an innovative provider of temperature-sensitive pharmaceutical supply chain solutions in the U.K. The acquisition further strengthens UPS's healthcare network across Europe, providing healthcare companies access to a single source for logistics solutions across the continent.

11 Feb 2014

SWHR comments on CBS 60 Minutes segment on how drugs uniquely affect men and women

The Society for Women's Health Research is the leading voice on research into the biological differences between women and men. SWHR President and CEO Phyllis Greenberger comments on the CBS 60 Minutes segment that aired February 9 on how drugs uniquely affect men and women

11 Feb 2014

Concussions account for 5.8% to 8.6% of injuries in soccer games

Soccer is the most-popular and fastest-growing sport in the world and, like many contact sports, players are at risk of suffering concussions from collisions on the field.

11 Feb 2014

Loyola pediatric dermatologists now offer same-day appointments to see kids

The next time your baby develops a rash or your teen has a severe acne outbreak, help is just a quick appointment away. Loyola University Health System pediatric dermatologists now offer same-day or next-day appointments to see your child.

11 Feb 2014

Unvaccinated flu patients need more intensive care

A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

11 Feb 2014

Study: Urgency incontinence is the most troubling urinary symptom in men and women

Urgency incontinence is considered the most troubling urinary symptom in both men and women, according to a recent study published in the leading urology journal, European Urology.

11 Feb 2014

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

University of Huddersfield lecturer Dr David Swann's design for a syringe that changes colour in order to deter its re-use - with the possibility of spreading dangerous infection - has already earned global interest. Now the project's profile will be raised higher still, following its shortlisting for a second major design award.

11 Feb 2014

Combination of SYK and FLT3 enzymes promotes progression of acute myelogenous leukemia

Reinforcing the need to look beyond genomic alterations to understand the complexity of cancer, researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center report that a normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme found in acute myelogenous leukemia (AML), to promote progression of the disease.

11 Feb 2014

Study findings suggest potential targets for treating HCV

The hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection. It also turns out that some people are genetically equipped with a strong countermeasure to the virus' attempt to weaken the attack on it.

11 Feb 2014

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

GenomOncology today announced a collaboration with Roswell Park Cancer Institute (RPCI) to develop an informatics solution that enables the association of Next Generation Sequencing results with knowledge resources to define actionable mutations.

11 Feb 2014